• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜内接入端口系统感染导致的结肠狭窄:胃癌伴腹膜转移行腹膜内化疗的一种罕见并发症。

Colonic stenosis caused by infection of an intraperitoneal access port system: a rare complication of intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis.

作者信息

Kinoshita Jun, Fushida Sachio, Tsukada Tomoya, Oyama Katsunobu, Watanabe Toshifumi, Okamoto Koichi, Makino Isamu, Nakamura Keishi, Hayashi Hironori, Nakagawara Hisatoshi, Miyashita Tomoharu, Tajima Hidehiro, Takamura Hiroyuki, Ninomiya Itasu, Kitagawa Hirohisa, Fujimura Takashi, Ohta Tetsuo

机构信息

Department of Gastroenterologic Surgery, Division of Cancer Medicine, Graduate School of Medical Science, Kanazawa University, 13-1 Takaramachi, Kanazawa, 920-8641, Japan.

出版信息

World J Surg Oncol. 2014 Jun 4;12:177. doi: 10.1186/1477-7819-12-177.

DOI:10.1186/1477-7819-12-177
PMID:24893606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4050104/
Abstract

BACKGROUND

Intraperitoneal (i.p.) chemotherapy is garnering attention as an effective treatment for gastric cancer with peritoneal metastasis. We report the case of a patient who developed colonic stenosis caused by infection of an i.p. access port system during i.p. chemotherapy. It was difficult to differentiate whether the extrinsic colonic stenosis arose from a catheter infection or peritoneal metastasis of the gastric cancer.

CASE PRESENTATION

A 66-year-old Japanese man underwent total gastrectomy for gastric cancer. Because the intraoperative findings revealed peritoneal metastasis, a port system was implanted for subsequent i.p. chemotherapy. Two months after initiation of chemotherapy, he complained of vomiting and abdominal pain. A computed tomography scan revealed marked thickening of the sigmoid colon wall adjacent to the catheter of the i.p. access port system. A barium enema demonstrated extrinsic irregular stenosis of the sigmoid colon. Although it was difficult to distinguish whether infection or peritoneal metastasis had caused the colonic stenosis, we removed the port system to obtain a therapeutic diagnosis. Coagulase-negative staphylococci were detected by catheter culture. The wall thickening and stenosis of the sigmoid colon completely resolved after removal of the port system.

CONCLUSIONS

We report the case of a rare complication in association with an i.p. access port system. Infection of the port system should be considered as a differential diagnosis when colonic stenosis adjacent to the catheter is observed during i.p. chemotherapy.

摘要

背景

腹腔内化疗作为治疗伴有腹膜转移的胃癌的一种有效方法正受到关注。我们报告了一例在腹腔内化疗期间因腹腔置入端口系统感染导致结肠狭窄的患者病例。很难区分结肠外源性狭窄是由导管感染还是胃癌腹膜转移引起的。

病例介绍

一名66岁的日本男性因胃癌接受了全胃切除术。由于术中发现有腹膜转移,植入了端口系统以便后续进行腹腔内化疗。化疗开始两个月后,他出现呕吐和腹痛。计算机断层扫描显示腹腔置入端口系统导管附近的乙状结肠壁明显增厚。钡灌肠显示乙状结肠有外源性不规则狭窄。尽管很难区分是感染还是腹膜转移导致了结肠狭窄,但我们移除了端口系统以进行治疗性诊断。导管培养检测到凝固酶阴性葡萄球菌。移除端口系统后,乙状结肠壁增厚和狭窄完全缓解。

结论

我们报告了一例与腹腔置入端口系统相关的罕见并发症病例。在腹腔内化疗期间观察到导管附近结肠狭窄时,应考虑端口系统感染作为鉴别诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dab/4050104/303f0d438082/1477-7819-12-177-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dab/4050104/866397277096/1477-7819-12-177-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dab/4050104/070e1f17c130/1477-7819-12-177-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dab/4050104/303f0d438082/1477-7819-12-177-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dab/4050104/866397277096/1477-7819-12-177-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dab/4050104/070e1f17c130/1477-7819-12-177-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dab/4050104/303f0d438082/1477-7819-12-177-3.jpg

相似文献

1
Colonic stenosis caused by infection of an intraperitoneal access port system: a rare complication of intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis.腹膜内接入端口系统感染导致的结肠狭窄:胃癌伴腹膜转移行腹膜内化疗的一种罕见并发症。
World J Surg Oncol. 2014 Jun 4;12:177. doi: 10.1186/1477-7819-12-177.
2
Complications and management of an implanted intraperitoneal access port system for intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis.胃癌合并腹膜转移行腹腔内化疗植入式腹腔内置管系统的并发症及处理。
Jpn J Clin Oncol. 2012 Nov;42(11):1013-9. doi: 10.1093/jjco/hys129. Epub 2012 Aug 7.
3
[Laparoscopic peritoneal dialysis catheter implantation in peritoneal chemotherapy for gastric cancer with peritoneal metastasis].腹腔镜下腹膜透析导管植入术在胃癌伴腹膜转移腹膜化疗中的应用
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Aug 25;22(8):774-780. doi: 10.3760/cma.j.issn.1671-0274.2019.08.013.
4
[Laparoscopic diagnosis of postoperative recurrence of peritoneal metastasis in gastric cancer patients and the clinical efficacy of bidirectional intraperitoneal and systemic chemotherapy].[腹腔镜诊断胃癌患者术后腹膜转移复发及双向腹腔内与全身化疗的临床疗效]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 May 25;23(5):492-498. doi: 10.3760/cma.j.cn.441530-20200415-00210.
5
[Repeated occlusion of the intraperitoneal access port for intraperitoneal chemotherapy in a patient with gastric cancer with peritoneal dissemination].[胃癌伴腹膜播散患者腹腔化疗腹腔置入端口的反复闭塞]
Gan To Kagaku Ryoho. 2013 Nov;40(12):2319-21.
6
[A Case of Sheath-Like Obstruction of the Entire Catheter in a Short Period of Time after Placement of an Intraperitoneal Access Port].[一例腹腔内留置穿刺端口后短期内整个导管出现鞘样阻塞的病例]
Gan To Kagaku Ryoho. 2022 Dec;49(13):1512-1514.
7
Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.采用静脉和腹腔注射紫杉醇联合口服S-1治疗的伴有腹膜转移的胃癌患者大量恶性腹水的无细胞浓缩腹水回输疗法(CART)
Eur J Surg Oncol. 2015 Jul;41(7):875-80. doi: 10.1016/j.ejso.2015.04.013. Epub 2015 May 8.
8
[Report of case who survived more than five years after repeated intraperitoneal chemotherapy with cisplatin and 5-fluorouracil for treatment of macroscopically negative but microscopically positive peritoneal dissemination of gastric cancer].[关于一名胃癌肉眼可见阴性但显微镜下阳性腹膜播散患者,经顺铂和5-氟尿嘧啶反复腹腔内化疗后存活超过五年的病例报告]
Gan To Kagaku Ryoho. 1998 Jul;25(9):1445-8.
9
A patient with gastric cancer with peritoneal carcinomatosis treated with intraperitoneal chemotherapy who survived more than 5 years receiving repeated laparoscopic examinations: a case report.一名患有胃癌伴腹膜转移的患者接受了腹腔内化疗,并在接受多次腹腔镜检查后存活超过5年:病例报告。
J Med Case Rep. 2016 Jan 19;10:14. doi: 10.1186/s13256-016-0799-5.
10
[An effective treatment by chemotherapy with S-1 and CDDP intraperitoneal administration for the peritoneal dissemination of gastric cancer--a case report].[S-1和顺铂腹腔内给药化疗对胃癌腹膜播散的有效治疗——病例报告]
Gan To Kagaku Ryoho. 2010 Nov;37(12):2442-4.

本文引用的文献

1
Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis.一项评估腹腔内多西紫杉醇联合 S-1 治疗腹膜转移胃癌患者的 I/II 期研究。
Cancer Chemother Pharmacol. 2013 May;71(5):1265-72. doi: 10.1007/s00280-013-2122-0. Epub 2013 Feb 20.
2
Phase II study of single intraperitoneal chemotherapy followed by systemic chemotherapy for gastric cancer with peritoneal metastasis.胃癌伴腹膜转移行单次腹腔化疗后继以全身化疗的 II 期临床研究。
J Gastrointest Surg. 2012 Dec;16(12):2190-6. doi: 10.1007/s11605-012-2059-3. Epub 2012 Oct 26.
3
Complications and management of an implanted intraperitoneal access port system for intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis.
胃癌合并腹膜转移行腹腔内化疗植入式腹腔内置管系统的并发症及处理。
Jpn J Clin Oncol. 2012 Nov;42(11):1013-9. doi: 10.1093/jjco/hys129. Epub 2012 Aug 7.
4
Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination.腹腔内多西紫杉醇联合 S-1 治疗伴有腹膜转移的晚期胃癌。
J Surg Oncol. 2012 Jan;105(1):38-42. doi: 10.1002/jso.22057. Epub 2011 Aug 31.
5
Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.每周静脉和腹腔内紫杉醇联合 S-1 治疗腹膜转移的晚期胃癌的 II 期研究。
Ann Oncol. 2010 Jan;21(1):67-70. doi: 10.1093/annonc/mdp260. Epub 2009 Jul 15.
6
Intraperitoneal cisplatin and paclitaxel in ovarian cancer.顺铂和紫杉醇腹腔内给药治疗卵巢癌
N Engl J Med. 2006 Jan 5;354(1):34-43. doi: 10.1056/NEJMoa052985.
7
Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study.在III期卵巢癌和原发性腹膜癌最佳分期患者中静脉化疗与腹腔化疗对比试验的腹腔导管结局:一项妇科肿瘤学组研究
Gynecol Oncol. 2006 Jan;100(1):27-32. doi: 10.1016/j.ygyno.2005.11.013.
8
Intraperitoneal therapy for stage III ovarian cancer: a therapy whose time has come!III期卵巢癌的腹腔内治疗:时机已至的一种治疗方法!
J Clin Oncol. 2002 Oct 1;20(19):3944-6. doi: 10.1200/JCO.2002.20.19.3944.
9
Complications associated with intraperitoneal chemotherapy catheters.与腹腔内化疗导管相关的并发症。
Gynecol Oncol. 2001 Apr;81(1):77-81. doi: 10.1006/gyno.2000.6108.
10
Celsite port and catheter as an intraperitoneal access device in the treatment of ovarian cancer.Celsite端口和导管作为一种腹腔内接入装置用于治疗卵巢癌。
J Surg Oncol. 2000 Jul;74(3):223-6. doi: 10.1002/1096-9098(200007)74:3<223::aid-jso14>3.0.co;2-q.